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Post Myocardial Infarction Risk Stratification: 1991 Perspective

Michael Lesch, MD'

T

he prospective identification of subsets of post myocardial
infarction (MI) patients at risk for increased cardiac mortality or morbidity has been termed "post-MI risk stratification."
By virtue of the research effort devoted to this topic, a number of
risk stratification variables have been identified and utilized to
develop management strategies for post-MI patients. Definition
of these techniques and strategies represents significant accomplishment, yet algorithms capable of defining specific risk categories in individual patients have yet to be developed. This goal
remains the objective of much research because the need to develop improved risk stratification strategies is pressing and apparent from a number of perspectives.
Achievement of accurate stratification methodologies would
allow for: I) improved post-MI care with resultant decreased
mortality and morbidity; 2) cost-efficient care (targeting expensive therapies and/or diagnostic techniques to populations likely to benefit from them); 3) rapid identification of different
pathophysiologic mechanisms that could guide specific therapy; 4) cost-efficient treatment trials since smaller numbers of
patients would need to bye enrolled in cooperative protocols if
endpoint incidence could be predicted more accurately; and 5)
the development of post-MI care guidelines for different patient
subsets based upon hard data, thus alleviating arbitrary regulatory mechanisms presently utilized by third-party bodies to control costs.
The impetus to develop post-MI risk stratification strategies
developed soon after research in the coronary care unit (CCU)
identified strategies capable of defining in-hospital morbidity
and mortality for the MI patient (1,2). Most studies of in-hospital mortality and morbidity also observed increased mortality in
post-MI patients in the period following discharge from the hospital regardless of apparent patient status (3-7). When controlling for all known predictors of mortality and morbidity in coronary disease (ventricular function, symptomatic state, presence
of congestive heart failure, and arrhythmia status), a comparison
of patients with chronic stable coronary disease to matched controls who were 0 to 18 months post MI revealed that the latter
group experienced significantly increased mortality and morbidity. This single factor—the inordinately high morbidity and
mortality of the immediate post-MI period—stands as the epidemiologic imperative defining the necessity to develop improved post-MI risk stratification strategies. The early post-MI
period is a perilous interval for the patient with coronary disease
and offers a window of opportunity in which finite benefit can
be provided to this patient population. Thus, while risk stratifi-
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cation has been a continuous theme of research in coronary artery disease for many years, the realization that the post-MI state
carries added risk for the coronary patient has served to focus attention on this particulartimeperiod.
The importance of defining quantifiable variables capable of
predicting risk not only in defined populations but also in individual patients was widely recognized by the mid 1970s, receiving particular impetus from the work of Arthur Moss (8) at the
University of Rochester, NY, and J. Thomas Bigger (9) of Columbia University. The current post-MI risk stratification literature is too large to be reviewed comprehensively in a single article. Therefore, this article will focus on the following aspects of
the risk stratification literature; 1) current concepts of post-MI
risk stratification, 2) methodologies used to stratify risk with
particular emphasis on problems inherent to such methodologies, and 3) specific problems regarding the application of postMI risk stratification studies to clinical practice.

Post-MI Risk Stratification:
Current State of the Art
In 1987, Moss et al (7) observed in their review that six major
pathophysiologic considerations formed the conceptual framework for post-MI risk stratification: 1) infarct size, 2) ventricular
function, 3) ventricular arrhythmias, 4) anginal status, 5) stress
testing, and 6) coronary angiography. While new techniques relevant to these six parameters have been introduced since 1987,
they can be analyzed within the format of the 1987 article with a
few notable exceptions. Thus, dipyridamole perfusion imaging
with thallium can be considered a variant of stress testing while
the signal-averaged ECG and analysis of heart rate variability
can be considered new methods for assessing the potential for
serious ventricular arrhythmia. Conversely, the potential role of
silent ischemia, thrombolytic therapy, and the concept of patent
infarct-related arteries as determinants of post-MI risk are not so
easily accommodated within the conceptual context of the 1987
article. The original Moss-Bigger-Odoroff format witi thus be
utilized herein to present currently available data with additional headings added as necessary to accommodate post-1987
concepts.
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Infarct size
The importance of infarct size in determining MI prognosis
was initially established from autopsy studies of patients with
cardiogenic shock or pump failure. These quantitative pathologic studies correlated pump failure to the total amount of necrotic myocardium, demonstrating that pump failure occurred
when more than 40% of the left ventricle had become infarcted.
Moreover, the timing of such necrosis was found not to be of importance (e.g., a single recent episode causing infarction of 40%
of the left ventricle was equivalent to an old 20% infarct and a
recent 20% infarct) (10-12). Recognition of the importance of
infarct size as a determinant of survivorship prompted investigation of techniques for measuring infarct size in vivo in acute
Ml patients. The original goal of measuring infarct size precisely and accurately in units of mass of infarcted myocardium
was not fully realized as the complexity of measuring infarct
size became apparent (13). However, while precise measurement of infarct size might not be possible, semi-quantitative estimation of relative infarct size was feasible (14). When these
techniques for semi-quantitative estimation of infarct size were
used to stratifyriskin surviving MI patients, an unequivocal relationship between infarct size and mortality (both early and
late) was established (7,14,15). This relation remains the keystone of risk stratification to this day. Issues conceming infarct
size that have not been definitively dealt with to date despite significant discussion in the literature relate to the equivalency of
equally sized infarcts in determining post-MI risk, when infarcts
are subcategorized as to type (Q wave versus non-Q wave infarcts) (16,17), location (anterior versus inferior) (18), or specific electrophysiologic effect (heart block, conduction disturbance, etc.) (19,20).

Ventricular function
Post-MI ventricular function, ostensibly a surrogate measurement of infarct size, has been directly measured both invasively
(21) and noninvasively (22) as well as indirectly estimated by
a variety of techniques ranging from clinical examination (23)
to chest x-ray analysis (24) to an ECG scoring system (25). The
pathologic data referenced above (10-12) have been evaluated
relative to ventricular function in survivors of acute MI and
summarized by Fetch (26) as follows:
"There is a good reladonship between the amounl of lefl
ventricular damage and the resulling physiology; less
lhan 10% loss and there is merely some reduction in left
ventricular ejection fraction. 15% loss is associated wilh
elevalion of filling pressure. 25% loss resulls in clinical
cardiac failure, and 40-50% resulls in cardiogenic shock,"
Despite the multiplicity of techniques available for the postMI estimation of left ventricular (LV) function and the numerous time points during and after hospitalization at which such
determinations could be made, multiple-gated image acquisition (MUGA) measurement of ejection fraction predischarge
has achieved de facto "gold standard" status as the technique of
choice. This status presumably derives from two factors: the
landmark data obtained from MUGA ejection fractions as re-
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ported by the Multicenter Postinfarction Research Group (22) in
1983, and the combined widespread availability and ease of reproducibility of this technique.
The landmark 1983 study (22) demonstrated a curvilinear relationship between one-year post-MI cardiac mortality and predischarge MUGA ejection fractions (Figure). While mortality
was minimally increased at decreasing levels of ejection fraction down to the 40% range, a dramatic increase in mortality was
noted at ejection fraction levels below 35%. All studies published on this topic, regardless of methodology utilized to measure LV function, confirm this general conclusion (7,21). Although discrepancies may exist as to what specific numerical
value for risk should be attributed to any given degree of ventricular dysfunction, the general curvilinear relationship between decreased ventricular function and increased post-MI
mortality is accepted as fact.
Arrhythmia analysis
Attempts to predict the risk for subsequent ventricular arrhythmia (ventricular tachycardia/ventricular fibrillation [VT/
VF]) and sudden cardiac death in post-MI subsets based upon
analysis of ambulatory ECG recordings were derived from early
CCU experience. The latter demonstrated ventricular ectopic
activity (VEA) to be a harbinger of more advanced forms of ventricular arrhythmia (VTA'F) in the setting of acute infarction
and that pharmacologic suppression of this VEA significantly
reduced the occurrence rate of VTA'F (17). To hypothesize that
VEA occurring in the post-hospital phase of coronary artery disease might have similar significance and that chronic antiarrhythmic therapy might have similar beneficial effect seemed
reasonable and a logical extension of known fact at the time
(27). Consequently, numerous centers tested the first half of this
hypothesis by obtaining pre or post discharge ambulatory ECGs
of various duration in MI patients and correlating the ECG data
vis-a-vis VEA to post-MI endpoints (usually sudden cardiac
death) (28). Although it appeared evident that the presence of
VEA was statistically associated with increased risk for subsequent cardiovascular morbidity, consensus could not be reached
regarding the precise quantitative implication of VEA. The inability to define with great precision the implications of VEA in
the post-MI period was to a significant degree related to two specific issues. First, there was no quantitative grading system for
VEA which accounted for both arrhythmia frequency and severity (29). No techniques existed then or now which would allow
for assessment of a single run of 3 beat VT on a 24-hour tape as
compared to one demonstrating five unifocal premature ventricular contractions per minute in each minute of the day. One is
more "severe," the other is more "frequent." The question of
which, if either, carries greater prognostic significance remains
unanswered. Second, data accumulated indicating that VEA
was not an independent marker of adverse prognosis, but rather
a dependent variable related primarily to compromised ventricular function (30-34). Numerous studies of the correlation between LV dysfunction and VEA supported the concept that
VEA was a surrogate marker of myocardial scar and thus ventricular dysfunction. Moss et al (7) addressed this issue and examined the data base from two large MI studies wherein both
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Figure—Cardiac mortality rate in four categories of radionuclide ejection fr action determined before hospital discharge
after myocardial infarction. (From the Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial Infarction. New Engl J Med 1983 ;309;331-6. Reprinted
with permission.)

LV function and VEA had been tabulated as a function of postMI mortality. They concluded that repetitive VEA (> 10 premature ventricular beats/hour) was strongly correlated to mortality
even after adjusting for LV dysfunction. VEA and LV dysfunction were shown in this analysis to be independent contributors
to post-MI mortality, with the predicted mortality for a patient
with both VEA and LV dysfunction being greater than the arithmetic sum ofeach individual risk factor. In other words, the two
risk factors positively interacted.
Attempts to use "stress testing" as a modality to expose latent
risk for arrhythmic death in post-MI populations have been disappointing. Treadmill testing to induce arrhythmia in the exercise state (7,35) (also see section entitied Exercise Testing) has
not provided improved prognostic indices in the post-MI patient. Initial experiences with electrophysiologic testing to induce arrhythmia with different stimulation protocols indicated
this technique was of marginal value in predicting the likelihood
of subsequent arrhythmia in the post-MI population (7,36). Recent experiences have demonstrated greater predictive value for
the technique (37,38), although the failure of this methodology
to gain wider clinical acceptance within the cardiology community at large represents indirect support for the skepticism expressed in an editorial review (39) of one of these latter (38) publications.
Two new methodologies not based upon the presence, absence, or inducibility of VEA have recentiy drawn attention as
techniques potentially capable of predicting risk of VT/VF in
post-MI populations. The "signal-averaged ECG" takes advan-
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tage ofthe observation that direct intraoperative epicardial electrograms, obtained at or near foci of spontaneous VTA'F generation in patients undergoing mapping studies, reveal fractionation ofthe terminal portion of the QRS, implying some form of
disordered impulse conduction at those sites. This fractionation
is not discemible with routine surface ECGs due to the very low
signal-to-noise ratio inherent to ECG signals in this portion of
the QRS complex. These observations stimulated development
of a technology to evaluate dispersion of terminal QRS forces
from surface ECGs by subjecting surface ECG data to "signal
averaging" so as to amplify the low voltage signals of interest.
While some initial reports suggest that an abnormal signal-averaged ECG in the post-MI period may be predictive of subsequent risk for VTAF, many details with this approach need to
be worked out before it can be considered clinically useful (4045).
Analysis of heart rate variability is a second, ambulatory
monitor-based, non-VEA-dependent methodology presently being evaluated as a post-MI risk stratification variable (46-48).
This technique takes advantage of the observation that normal
cardiovascular function is characterized by a rather large variation in heart rate throughout the day. Conversely, progressive
degrees of impaired cardiovascular function, and thus presumably increased risk for sudden cardiac death, is characterized by
decreased heart rate variability. This technique, like the signalaveraged ECG, may hold significant promise as a risk stratification variable. However, the two techniques share the common
drawback of not yet having been studied adequately for this purpose to be of proven clinical utility.
Postinfarction angina
The long-term prognostic implication of anginal syndromes
in the immediate post-MI phase is not likely to be investigated
further given recent conceptual changes regarding our understanding of the mechanisms operative in the pathophysiology of
postinfarction angina and infarction (49,50), the introduction of
thrombolytic and anticoagulant therapy (51), the widespread
availability of percutaneous transluminal coronary angioplasty,
and the commonly held precept that postinfarction angina implies tbe need for revascularization therapy (52,53). In the current therapeutic climate, the pressure to treat post-MI ischemia
manifesting as anginal pain is so overwhelming that a controlled
study designed to analyze the prognostic implication of angina
in the immediate post-MI period is not feasible. The consensus
that MI patients who manifest early post-MI ischemia are at
greater risk than those without such manifestations is based
upon considerable experience and probably should be accepted.
Exercise stress testing
The specificity and sensitivity of exercise stress testing using
the ECG, LV function analysis, or perfusion scanning either singly or in combination for the detection of coronary artery disease have been well delineated (54-58). Although the sensitivity
and specificity of these techniques are far from perfect and the
precision and accuracy with which they can predict future morbid events are even less perfect, data derived from these tests
have been developed into meaningful algorithms for evaluation
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ofthe patient with stable ischemic heart disease. In patients with
stable documented or suspected coronary disease, the utility of
stress testing is largely due to the use of standardized protocols
for test performance and interpretation. A similar degree of
"standardization" is not available in post-MI stress testing. Different centers utilize different exercise protocols and endpoints
and perform the test at different times post-MI, thus making it
impossible to develop any general statement about this procedure. As exemplified by a number of recent publications, not
much consensus exists as to what specific endpoints in what
specific protocols have what specific implication in the post-MI
population at large (59-64). While there appears to be some
agreement that ST segment depression is not as important an
endpoint and that evidence of LV dysfunction (maximum metabolic equivalents achieved, blood pressure response) is more
important as compared to similar testing in chronic stable populations, post-MI stress testing remains a commonly used procedure in clinical practice which remains incompletely defined
and characterized.
Coronary angiography
The pattem of the progression of coronary atherosclerosis
was initially defined from serial angiographic analysis. The major conclusion derived from these studies which analyzed retrospectively populations of patients who had undergone angiography on at least two occasions for diverse reasons was that progression of coronary atherosclerosis is unpredictable (65-67). In
these studies high-grade lesions frequentiy were found to be stable over many years while total occlusions developed within a
short term at sites which had been normal or minimally diseased
at thetimeof initial study. This observation was confirmed prospectively in a post-MI population by Littie et al (68). These investigators performed angiography on a Ml population at or
around thetimeof the index MI. Those patients not subjected to
revascularization procedures who sustained a subsequent MI
were submitted to repeat angiography at the time of the second
event to define the culprit lesion and/or infarct-related artery of
the second event. The data indicated that the vascular site responsible for the second MI could not be predicted on the basis
of lesion anatomy defined by the angiogram performed immediately after the first MI.
These puzzling data went unexplained until Davies and others (49-51) demonstrated, using pathologic technique and analysis, that the rapid deterioration (development of infarction or
an unstable anginal syndrome) of a patient with previously stable coronary atherosclerosis was due not to progression of the
atherosclerotic process but to the rupture of the fibrous cap overlying atherosclerotic lesions and the subsequent formation of total or subtotal occlusive thrombotic plugs at the mpture site as
blood was exposed to the thrombogenic infiuence of the lipid
and collagen which comprise the bulk of an atherosclerotic lesion. It was further demonstrated that the likelihood of fibrous
cap mpture was not related to the initial degree of lesion severity, thus explaining the previously enigmatic "random" progression of coronary atherosclerosis.
In view of these considerations, coronary angiography is best
conceptualized as a technique for evaluating the anatomic status
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ofthe coronary arterial tree at a given point in time. It offers little
in the way of predictive capability regarding either the site or
rate of disease progression and is thus of limited value as a predictive post-MI risk stratification variable.
New concepts
The majority of available post-MI stratification data predate
the widespread use of thrombolytic therapy. It is unclear if presently held concepts regarding stratification need to be modified
in the thrombolytic era. One concept emanating from the thrombolytic experience that may significantly impact stratification
studies and strategies is that of the "patent infarct-related artery"
(69). In some patients where thrombolysis is achieved, it occurs
too late to salvage any myocardium. Patients left with such an
infarct and a patent infarct-related artery experience fewer episodes of death and/or sudden cardiac death following infarction.
Patients with a given mass of infarcted tissue and a patent infarct-related artery are less likely to have electrophysiologic
findings associated with an increased risk for sudden cardiac
death (70-76) compared to patients with an occluded infarct artery. If thesefindingsare substantiated, the implication for the
rouline management of post-MI patients will be profound. Such
substantiation would justify attempts to open infarct-related arteries, even after infarction has occurred, with thrombolytic or
mechanical approaches.
A second emerging concept relative to post-MI stratification
relates to the general topic of silent ischemia (77,78). The significance and relevance of silent ischemia is presentiy being evaluated in numerous subsets of coronary disease patients, and a
firm statement relative to post-MI stratification would be premature. What is apparent at this juncture, however, is that ischemia, be it painful or painless, is of definite significance in patients with coronary disease. Whether these two syndromes are
of "equal" significance and prognostic importance remains to
be determined.

Methodologic Problems Inherent to
Post-MI Risk stratification Studies
All risk stratification studies test the general hypothesis that a
particular study parameter (e.g., LV function, arrhythmia status,
heart rate variability, exercise tolerance), when measured at
some defined time point (e.g., on admission to CCU, before
CCU discharge or at hospital discharge), defines subset groups
within a large MI patient population with differentrisksfor certain predetermined endpoints (e.g., death, sudden cardiac death,
reinfarction, unstable angina, or need for revascularization surgery). Patient populations used for these studies have been obtained retrospectively (79), prospectively (80), or by a combination approach with retrospective analysis of a data base obtained
from MI patients studied for some other protocol (7).
In recent years clinical investigators have become sensitive to
(and more sophisticated with) statistical issues in clinical research. Accordingly, most post-MI risk stratification studies
demonstrate considerable expertise regarding both the statistical definition of the Ml population(s) studied, the data to be analyzed, and the techniques utilized for analysis. Despite the vig-
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orous statistical techniques applied to post-MI risk stratification
studies, conclusions drawn from such studies remain potentially
inaccurate due to the very nature of the problem being studied.
All attempts to study post-MI risk stratification, no matter
what inclusion/exclusion criteria are used to construct the study
group(s), perforce make the assumption that the study group(s)
is(are) statistically identical. This assumption requires that the
Ml population be homogeneous or, if heterogeneous, that the
statistical variation raised by such heterogeneity can be overcome by studying increased numbers and thus "averaging out"
any differences. The probability that these requirements can be
achieved is questionable.
The inherent, complex heterogeneity of the MI patient population and the potential fallacy behind the strategy of averaging
out hidden differences between such populations by studying
large numbers of patients have been previously discussed by
Kelly (81) who states:
"A further caveat is that, while management and treatment in our conlemporary medical limes is deiermined by
the response of a large series of patients in controlled trials, physicians treat individuals, and it is he or she who
must have risk determined, investigated, and ireated appropriately. Although most series, and panicularly those
evaluating treatment following myocardial infarction,
contain large numbers of patients, il is important and cannot be emphasized strongly enough that these patients
represent the pooled dala base of patients of diverse ages,
disease states, and thus prognosis. While such informalion from these .studies is valuable, myocardial infarction
is not a homogeneous enlity. ll is complex and heterogeneous and this again emphasizes that the physician must
evaluate each individual patient."
Issues such as differences in age, sex, number of previous infarcts, infarct location, and infarct type (Q wave versus non-Q
wave) are further discussed by Kelly (81). Topics which are
more complex and are not discussed, thus posing greater statistical methodologic challenges, include the following:
1. In studies of patients with first Mls, the historical presence/
absence of angina is frequently tabulated, but the clinical and
temporal pattem of the angina is usually not. Two patients with
a first MI and a history of angina will be inappropriately considered statistically identical even if in one the anginal pattem was
of a chronic stable type of five years' duration while in the second there was afive-dayhistory of acute onset unstable angina.
2. In patients with second Mls, how should the duration between the historical Ml and the index MI be dealt with? Should
one consider patients with a second Ml to be statistically identical ifthe duration between Mls is two weeks versus two months
versus two years versus two decades?
Many more examples of true infarct population heterogeneity, despite apparent statistical homogeneity, could be provided.
The issue to recognize is that just as there exists no American
family with 2.3 children and 1.7 parents living at home, there exists no average infarct patient. The concept of an average infarct
population, while scientifically valid in the statistical sense for
analysis of population subsets, suffers from an inability to mod-
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el adequately the multiple complexities of the infarct population
so as to make comparisons between a given individual patient
and the average population valid. Altematively stated, our inability to define all pertinent patient variables when attempting
to study post-MI risk stratification results in our statistical approach being inadequately "robust."
A second methodologic problem inherent to all post-MI risk
stratification studies is best described as "endpoint ambiguity."
The term ambiguity is used because death, reinfarction and/or
the development of angina, or the need for revascularization are
commonly used as endpoints in post-MI risk stratification studies. The use of such endpoints mandates the assumption that the
particular endpoint under consideration either results from, is
directiy caused by, or is an immediate complication of the index
MI, i.e., the Ml which caused the patient to be entered into the
study in the first place. Because coronary atherosclerosis tends
to be a progressive disease, such progression is not necessarily
limited to the infarct-related artery of the index MI, and progression in non-infarct-related arteries can also result in death, reinfarction and/or the development of angina, or the need for revascularization, and thus ambiguity results. If a subject in a postMI risk stratification study experiences sudden death six to 12
months post-MI, how can it be determined whether that episode
of sudden cardiac death was mediated by the scar and/or resultant ischemia related to the index infarct as opposed to progression of atherosclerosis and/or acute thrombotic occlusion of a
remote non-infarct-related artery? The death, while considered a
hard endpoint for the study, is nonetheless an ambiguous endpoint since it cannot definitely be considered as a complication
of the original infarct.

Future Challenges: Statistical Significance
Versus Clinical Importance
This review has attempted to analyze for the clinician the
present status of post-MI risk stratification. The obvious conclusions from the material presented are that, statistically speaking,
the worse the LV function, the greater the degree of arrhythmia
or potential for arrhythmia, and the greater the degree of residual
ischemic myocardium at risk, the worse the prognosis. While
different mortality/morbidity rates can be defined for population subsets, and statistical significance of these differences calculated, the accurate calculation of a precise risk for a given patient is not yet possible.
There is yet another caveat about post-MI risk stratification.
Using the data in the Figure as a prototype, the issue raised is
that while specific factors which carry exceedingly high risk for
mortality or morbidity can be identified (e.g., LV ejection fraction < 20%), the fraction of MI patients that fall into these highrisk categories is so small that the total number of morbid events
accounted for by the "high-risk group" represents the minority
of events that occur in the total MI population. The data from the
Figure are presented in tabular form in the Table which includes
a data set for absolute number of deaths accounted for in each
LV ejection fraction subgroup. From the Table, the following is
obvious: 1) of 64 total deaths, only 10 (16%) occurred in the
highest risk group; 2) the two lowest risk subgroups accounted
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Table
Mortality Rate and Absolute Numbers of
Deaths as a Function of LVEF*
LVEF
<20%
20%-39%
40%-59%
>60%

Number of
Patients

Mortality
Rate

21
244
382
152

47%
12%
5%
4%

Calculated Number
of Deaths
10
29
!9

6

*Data from the Figure presented in tabular form,
LVEF = left ventricular ejection fraction.

for a total of 25 deaths (39%); and 3) depending upon the value
chosen to represent the true infiection point of the curve depicted in the Figure, since the group defined as having LV ejection fractions in the 20% to 39% range clearly straddles this
point, it is highly probable that more than 50% of the total deaths
occurred in patients with a LV ejection fraction > 35%, i.e., a
subgroup defined as being at low relative risk. When a similar
analysis is applied to any other stratifying variable in any of a
number of studies, a similar pattem emerges. Thus, one must
conclude that presently recognized risk stratification strategies
do not identify the majority of patients who will experience
morbidity or mortality in the dangerous interlude that follows
acute MI. Altematively stated, while it takes no great cardiologic wisdom in 1991 to recognize that a post-MI patient with an
LV ejection fraction of < 20%, high-grade VEA, and poor exercise tolerance is at high risk for cardiac mortality and morbidity,
it remains frustrating that the majority of patients experiencing
early post-MI morbidity are relatively healthy in a cardiac sense,
insofar as our major stratifying variables are concerned. The
challenge of the future is not only to prolong the life of the patient with poor LV function and arrhythmia but also to identify
why and who of the ostensibly healthy post-MI patients will experience early morbidity or mortalily.
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